Cargando…

Approaches to the treatment of disease induced by chikungunya virus

Chikungunya virus, a re-emerging mosquito-borne alphavirus, causes fever, rash and persistent arthralgia/arthritis in humans. Severe outbreaks have occurred resulting in infections of millions of people in Southeast Asia and Africa. Currently there are no antiviral drugs or vaccines for prevention a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettadapura, Jayaram, Herrero, Lara J., Taylor, Adam, Mahalingam, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928707/
https://www.ncbi.nlm.nih.gov/pubmed/24434329
_version_ 1782304302119780352
author Bettadapura, Jayaram
Herrero, Lara J.
Taylor, Adam
Mahalingam, Suresh
author_facet Bettadapura, Jayaram
Herrero, Lara J.
Taylor, Adam
Mahalingam, Suresh
author_sort Bettadapura, Jayaram
collection PubMed
description Chikungunya virus, a re-emerging mosquito-borne alphavirus, causes fever, rash and persistent arthralgia/arthritis in humans. Severe outbreaks have occurred resulting in infections of millions of people in Southeast Asia and Africa. Currently there are no antiviral drugs or vaccines for prevention and treatment of chikungunya infections. Herein we report the current status of research on antiviral drugs and vaccines for chikungunya virus infections.
format Online
Article
Text
id pubmed-3928707
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39287072014-03-03 Approaches to the treatment of disease induced by chikungunya virus Bettadapura, Jayaram Herrero, Lara J. Taylor, Adam Mahalingam, Suresh Indian J Med Res Review Article Chikungunya virus, a re-emerging mosquito-borne alphavirus, causes fever, rash and persistent arthralgia/arthritis in humans. Severe outbreaks have occurred resulting in infections of millions of people in Southeast Asia and Africa. Currently there are no antiviral drugs or vaccines for prevention and treatment of chikungunya infections. Herein we report the current status of research on antiviral drugs and vaccines for chikungunya virus infections. Medknow Publications & Media Pvt Ltd 2013-11 /pmc/articles/PMC3928707/ /pubmed/24434329 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bettadapura, Jayaram
Herrero, Lara J.
Taylor, Adam
Mahalingam, Suresh
Approaches to the treatment of disease induced by chikungunya virus
title Approaches to the treatment of disease induced by chikungunya virus
title_full Approaches to the treatment of disease induced by chikungunya virus
title_fullStr Approaches to the treatment of disease induced by chikungunya virus
title_full_unstemmed Approaches to the treatment of disease induced by chikungunya virus
title_short Approaches to the treatment of disease induced by chikungunya virus
title_sort approaches to the treatment of disease induced by chikungunya virus
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928707/
https://www.ncbi.nlm.nih.gov/pubmed/24434329
work_keys_str_mv AT bettadapurajayaram approachestothetreatmentofdiseaseinducedbychikungunyavirus
AT herrerolaraj approachestothetreatmentofdiseaseinducedbychikungunyavirus
AT tayloradam approachestothetreatmentofdiseaseinducedbychikungunyavirus
AT mahalingamsuresh approachestothetreatmentofdiseaseinducedbychikungunyavirus